Canaccord Genuity maintains DexCom (NASDAQ:DXCM) with a Buy and raises the price target from $185 to $195.
Canaccord Genuity Maintains Buy on DexCom, Raises Price Target to $195
Canaccord Genuity maintains DexCom (NASDAQ:DXCM) with a Buy and raises the price target from $185 to $195.
Benzinga · 11/07/2019 15:52